The anti-angiogenic and cytotoxic effects of the boswellic acid analog BA145 are potentiated by autophagy inhibitors

Anup S. Pathania, Zahoor A. Wani, Santosh K. Guru, Suresh Kumar, Shashi Bhushan, Hasan Korkaya, Darren F. Seals, Ajay Kumar, Dilip M. Mondhe, Zabeer Ahmed, Bal K. Chandan, Fayaz Malik

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: While angiogenesis inhibitors represent a viable cancer therapy, there is preclinical and clinical data to suggest that many tumors develop resistance to such treatments. Moreover, previous studies have revealed a complex association between autophagy and angiogenesis, and their collective influence on tumorigenesis. Autophagy has been implicated in cytoprotection and tumor promotion, and as such may represent an alternative way of targeting apoptosis-resistant cancer cells. This study explored the anti-cancer agent and boswellic acid analog BA145 as an inducer of autophagy and angiogenesis-mediated cytoprotection of tumor cells. Methods: Flow cytometry, western blotting, and confocal microscopy were used to investigate the role of BA145 mediated autophagy. ELISA, microvessel sprouting, capillary structure formation, aortic ring and wound healing assays were performed to determine the relationship between BA145 triggered autophagy and angiogenesis. Flow cytometery, western blotting, and microscopy were employed to examine the mechanism of BA145 induced cell death and apoptosis. Live imaging and tumor volume analysis were carried out to evaluate the effect of BA145 triggered autophagy on mouse tumor xenografts. Results: BA145 induced autophagy in PC-3 cancer cells and HUVECs significantly impeded its negative regulation on cell proliferation, migration, invasion and tube formation. These effects of BA145 induced autophagy were observed under both normoxic and hypoxic conditions. However, inhibition of autophagy using either pharmacological inhibitors or RNA interference enhanced the BA145 mediated death of these cells. Similar observations were noticed with sunitinib, the anti-angiogenic properties of which were significantly enhanced during combination treatments with autophagy inhibitors. In mouse tumor xenografts, co-treatment with chloroquinone and BA145 led to a considerable reduction in tumor burden and angiogenesis compared to BA145 alone. Conclusion: These studies reveal the essential role of BA145 triggered autophagy in the regulation of angiogenesis and cytoprotection. It also suggests that the combination of the autophagy inhibitors with chemotherapy or anti-angiogenic agents may be an effective therapeutic approach against cancer.

Original languageEnglish (US)
Article number6
JournalMolecular cancer
Volume14
Issue number1
DOIs
StatePublished - Jan 21 2015

Fingerprint

Autophagy
Neoplasms
Cytoprotection
Tumor Burden
Heterografts
boswellic acid
Cell Death
Western Blotting
Apoptosis
Therapeutics
Angiogenesis Inhibitors
Angiogenesis Inducing Agents
Human Umbilical Vein Endothelial Cells
RNA Interference
Microvessels
Confocal Microscopy
Wound Healing
Cell Movement
Microscopy
Flow Cytometry

Keywords

  • Angiogenesis
  • Autophagy
  • BA145
  • Chloroquinone (CQ)
  • Hypoxia
  • Light chain protein 3 (LC3)
  • Vascular endothelial growth factor receptor-2 (VEGFR-2)

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research

Cite this

The anti-angiogenic and cytotoxic effects of the boswellic acid analog BA145 are potentiated by autophagy inhibitors. / Pathania, Anup S.; Wani, Zahoor A.; Guru, Santosh K.; Kumar, Suresh; Bhushan, Shashi; Korkaya, Hasan; Seals, Darren F.; Kumar, Ajay; Mondhe, Dilip M.; Ahmed, Zabeer; Chandan, Bal K.; Malik, Fayaz.

In: Molecular cancer, Vol. 14, No. 1, 6, 21.01.2015.

Research output: Contribution to journalArticle

Pathania, AS, Wani, ZA, Guru, SK, Kumar, S, Bhushan, S, Korkaya, H, Seals, DF, Kumar, A, Mondhe, DM, Ahmed, Z, Chandan, BK & Malik, F 2015, 'The anti-angiogenic and cytotoxic effects of the boswellic acid analog BA145 are potentiated by autophagy inhibitors', Molecular cancer, vol. 14, no. 1, 6. https://doi.org/10.1186/1476-4598-14-6
Pathania, Anup S. ; Wani, Zahoor A. ; Guru, Santosh K. ; Kumar, Suresh ; Bhushan, Shashi ; Korkaya, Hasan ; Seals, Darren F. ; Kumar, Ajay ; Mondhe, Dilip M. ; Ahmed, Zabeer ; Chandan, Bal K. ; Malik, Fayaz. / The anti-angiogenic and cytotoxic effects of the boswellic acid analog BA145 are potentiated by autophagy inhibitors. In: Molecular cancer. 2015 ; Vol. 14, No. 1.
@article{7be350fe0a80466f9ee90826805b856b,
title = "The anti-angiogenic and cytotoxic effects of the boswellic acid analog BA145 are potentiated by autophagy inhibitors",
abstract = "Background: While angiogenesis inhibitors represent a viable cancer therapy, there is preclinical and clinical data to suggest that many tumors develop resistance to such treatments. Moreover, previous studies have revealed a complex association between autophagy and angiogenesis, and their collective influence on tumorigenesis. Autophagy has been implicated in cytoprotection and tumor promotion, and as such may represent an alternative way of targeting apoptosis-resistant cancer cells. This study explored the anti-cancer agent and boswellic acid analog BA145 as an inducer of autophagy and angiogenesis-mediated cytoprotection of tumor cells. Methods: Flow cytometry, western blotting, and confocal microscopy were used to investigate the role of BA145 mediated autophagy. ELISA, microvessel sprouting, capillary structure formation, aortic ring and wound healing assays were performed to determine the relationship between BA145 triggered autophagy and angiogenesis. Flow cytometery, western blotting, and microscopy were employed to examine the mechanism of BA145 induced cell death and apoptosis. Live imaging and tumor volume analysis were carried out to evaluate the effect of BA145 triggered autophagy on mouse tumor xenografts. Results: BA145 induced autophagy in PC-3 cancer cells and HUVECs significantly impeded its negative regulation on cell proliferation, migration, invasion and tube formation. These effects of BA145 induced autophagy were observed under both normoxic and hypoxic conditions. However, inhibition of autophagy using either pharmacological inhibitors or RNA interference enhanced the BA145 mediated death of these cells. Similar observations were noticed with sunitinib, the anti-angiogenic properties of which were significantly enhanced during combination treatments with autophagy inhibitors. In mouse tumor xenografts, co-treatment with chloroquinone and BA145 led to a considerable reduction in tumor burden and angiogenesis compared to BA145 alone. Conclusion: These studies reveal the essential role of BA145 triggered autophagy in the regulation of angiogenesis and cytoprotection. It also suggests that the combination of the autophagy inhibitors with chemotherapy or anti-angiogenic agents may be an effective therapeutic approach against cancer.",
keywords = "Angiogenesis, Autophagy, BA145, Chloroquinone (CQ), Hypoxia, Light chain protein 3 (LC3), Vascular endothelial growth factor receptor-2 (VEGFR-2)",
author = "Pathania, {Anup S.} and Wani, {Zahoor A.} and Guru, {Santosh K.} and Suresh Kumar and Shashi Bhushan and Hasan Korkaya and Seals, {Darren F.} and Ajay Kumar and Mondhe, {Dilip M.} and Zabeer Ahmed and Chandan, {Bal K.} and Fayaz Malik",
year = "2015",
month = "1",
day = "21",
doi = "10.1186/1476-4598-14-6",
language = "English (US)",
volume = "14",
journal = "Molecular Cancer",
issn = "1476-4598",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The anti-angiogenic and cytotoxic effects of the boswellic acid analog BA145 are potentiated by autophagy inhibitors

AU - Pathania, Anup S.

AU - Wani, Zahoor A.

AU - Guru, Santosh K.

AU - Kumar, Suresh

AU - Bhushan, Shashi

AU - Korkaya, Hasan

AU - Seals, Darren F.

AU - Kumar, Ajay

AU - Mondhe, Dilip M.

AU - Ahmed, Zabeer

AU - Chandan, Bal K.

AU - Malik, Fayaz

PY - 2015/1/21

Y1 - 2015/1/21

N2 - Background: While angiogenesis inhibitors represent a viable cancer therapy, there is preclinical and clinical data to suggest that many tumors develop resistance to such treatments. Moreover, previous studies have revealed a complex association between autophagy and angiogenesis, and their collective influence on tumorigenesis. Autophagy has been implicated in cytoprotection and tumor promotion, and as such may represent an alternative way of targeting apoptosis-resistant cancer cells. This study explored the anti-cancer agent and boswellic acid analog BA145 as an inducer of autophagy and angiogenesis-mediated cytoprotection of tumor cells. Methods: Flow cytometry, western blotting, and confocal microscopy were used to investigate the role of BA145 mediated autophagy. ELISA, microvessel sprouting, capillary structure formation, aortic ring and wound healing assays were performed to determine the relationship between BA145 triggered autophagy and angiogenesis. Flow cytometery, western blotting, and microscopy were employed to examine the mechanism of BA145 induced cell death and apoptosis. Live imaging and tumor volume analysis were carried out to evaluate the effect of BA145 triggered autophagy on mouse tumor xenografts. Results: BA145 induced autophagy in PC-3 cancer cells and HUVECs significantly impeded its negative regulation on cell proliferation, migration, invasion and tube formation. These effects of BA145 induced autophagy were observed under both normoxic and hypoxic conditions. However, inhibition of autophagy using either pharmacological inhibitors or RNA interference enhanced the BA145 mediated death of these cells. Similar observations were noticed with sunitinib, the anti-angiogenic properties of which were significantly enhanced during combination treatments with autophagy inhibitors. In mouse tumor xenografts, co-treatment with chloroquinone and BA145 led to a considerable reduction in tumor burden and angiogenesis compared to BA145 alone. Conclusion: These studies reveal the essential role of BA145 triggered autophagy in the regulation of angiogenesis and cytoprotection. It also suggests that the combination of the autophagy inhibitors with chemotherapy or anti-angiogenic agents may be an effective therapeutic approach against cancer.

AB - Background: While angiogenesis inhibitors represent a viable cancer therapy, there is preclinical and clinical data to suggest that many tumors develop resistance to such treatments. Moreover, previous studies have revealed a complex association between autophagy and angiogenesis, and their collective influence on tumorigenesis. Autophagy has been implicated in cytoprotection and tumor promotion, and as such may represent an alternative way of targeting apoptosis-resistant cancer cells. This study explored the anti-cancer agent and boswellic acid analog BA145 as an inducer of autophagy and angiogenesis-mediated cytoprotection of tumor cells. Methods: Flow cytometry, western blotting, and confocal microscopy were used to investigate the role of BA145 mediated autophagy. ELISA, microvessel sprouting, capillary structure formation, aortic ring and wound healing assays were performed to determine the relationship between BA145 triggered autophagy and angiogenesis. Flow cytometery, western blotting, and microscopy were employed to examine the mechanism of BA145 induced cell death and apoptosis. Live imaging and tumor volume analysis were carried out to evaluate the effect of BA145 triggered autophagy on mouse tumor xenografts. Results: BA145 induced autophagy in PC-3 cancer cells and HUVECs significantly impeded its negative regulation on cell proliferation, migration, invasion and tube formation. These effects of BA145 induced autophagy were observed under both normoxic and hypoxic conditions. However, inhibition of autophagy using either pharmacological inhibitors or RNA interference enhanced the BA145 mediated death of these cells. Similar observations were noticed with sunitinib, the anti-angiogenic properties of which were significantly enhanced during combination treatments with autophagy inhibitors. In mouse tumor xenografts, co-treatment with chloroquinone and BA145 led to a considerable reduction in tumor burden and angiogenesis compared to BA145 alone. Conclusion: These studies reveal the essential role of BA145 triggered autophagy in the regulation of angiogenesis and cytoprotection. It also suggests that the combination of the autophagy inhibitors with chemotherapy or anti-angiogenic agents may be an effective therapeutic approach against cancer.

KW - Angiogenesis

KW - Autophagy

KW - BA145

KW - Chloroquinone (CQ)

KW - Hypoxia

KW - Light chain protein 3 (LC3)

KW - Vascular endothelial growth factor receptor-2 (VEGFR-2)

UR - http://www.scopus.com/inward/record.url?scp=84937721870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937721870&partnerID=8YFLogxK

U2 - 10.1186/1476-4598-14-6

DO - 10.1186/1476-4598-14-6

M3 - Article

C2 - 25608686

AN - SCOPUS:84937721870

VL - 14

JO - Molecular Cancer

JF - Molecular Cancer

SN - 1476-4598

IS - 1

M1 - 6

ER -